A drug currently being used to treat ischemic strokes may prove to be a significant advance in the treatment of tuberculosis and ulcers. In a new research report appearing online in The FASEB Journal, a compound called ebselen effectively inhibits the thioredoxin reductase system in a wide variety of bacteria, including Helicobacter pylori which causes gastric ulcers and Mycobacterium tuberculosis which causes tuberculosis. Thioredoxin and thioredoxin reductase proteins are essential for bacteria to make new DNA, and protect them against oxidative stress caused by the immune system. Targeting this system with ebselen, and others compounds like it, represents a new approach toward eradicating these bacteria.
"This new antibacterial principle provides better chances of surviving an infection," said Arne Holmgren, M.D., Ph.D., a researcher involved in the work from the Division of Biochemistry in the Department of Medical Biochemistry and Biophysics, at Karolinska Institutet in Stockholm, Sweden. "Since ebselen is also an antioxidant, the present mechanism can be described as a 'two for the price of one' antioxidant action in inflammation, and specific targeting of multi-resistant bacterial complications and sepsis."
Building on previous observations where ebselen has shown antibacterial properties against some bacteria, Holmgren and colleagues hypothesized that the bacteria sensitive to ebselen relied solely on thioredoxin and thioredoxin reductase for essential cellular processes. They investigated this by testing it on strains of E. coli with deletions in the genes for thioredoxin, thioredoxin reductase and the glutaredoxin system. They found that strains with deletions in the genes coding for glutaredoxin system were much more sensitive than normal bacteria. Researchers further tested ebselen against Helicobacter pylori and Mycobacterium tuberculosis, which both naturally lack the glutaredoxin system and are frequently resistant to many commonly used antibiotics, and found both to be sensitive to ebselen.
"As rapidly as these organisms evolve, we need new drugs sooner rather than later," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "The fact that these scientists have found a new target for killing some of the most resistant bacteria is great news, but the fact that we already have at least one drug which we could possibly use now makes the news even better."
Federation of American Societies for Experimental Biology: http://www.faseb.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Research suggests that goalkeepers can influence the accuracy of penalty shots by assuming a posture that mimics a classic optical illusion.
Thousands log on to transcribe handwritten catalogue dating back to 18th century and put 30,000 ancient objects online
When Kim Goodsell discovered that she had two extremely rare genetic diseases, she taught herself genetics to help
East and West African pygmies evolved their stature independently, possibly because it was a beneficial trait in an environment packed with low obstacles
Alastair Bland looks at the dangers to real sharks and the hazards of pseudo-documentaries as another Shark Week draws to a close.
Proof-of-principle experiment shows gene-editing can be used to prevent muscle wasting in Duchenne muscular dystrophy
Could the serum contain the spread of the disease? Is the vaccine dangerous? An immunologist gives us the lowdown Ebola: voices from the epicentre of the epidemic
Clouds can carry millions of pounds of water, but that doesn’t mean rain and snow just happen. Hundreds of thousands of water vapor molecules need to freeze together as ice before they are heavy enough to fall to the ground.
Rather than emerging in protected coves, baby blue sharks spend their first years in a big patch of open ocean
Medical breakthrough as researchers uncover the mystery of how hematopoietic stem cells form